← All stocks

CVRx, Inc.

CVRX Net buying
CIK 0001235912 #4489 in the set updated 18 Sep 2026
Bought (120 mo)
$26.47M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.02M
$129.91K on a plan · $245.87K straight out of an exercise
Sold at will
$648.65K
7 of 19 sales
Net
+$25.44M
+$25.82M against sales at will

By person

27 insiders · 134 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GSK plc entity
10% owner
$4.95M (1)
+$4.95M
1,007,583
3.78%
$2.94M
+3,067%
Pardo Geoffrey B
Director
$4.95M (1)
+$4.95M
1,829,022
6.87%
$5.33M
NEA PARTNERS 10 L P entity
10% owner
$4.50M (2)
+$4.50M
2,199,471
8.26%
$6.41M
+158,821%
Jain Mudit K.
Director
$4.37M (10)
+$4.37M
1,927,936
7.24%
$5.62M
+106.6%
NEW ENTERPRISE ASSOCIATES 10 L P entity
10% owner
$4.06M (1)
+$4.06M
2,026,083
7.60%
$5.91M
Nielsen Kirk G.
Director
$2.71M (17)
+$2.71M
3,380,685
12.69%
$9.85M
+131.3%
JOHNSON & JOHNSON
10% owner
$733.14K (7)
−$733.14K
7,536,436
28.29%
$21.97M
+115.6%
NEHRA JOHN M
Director
$502.65K (3)
+$502.65K
28,366
0.1065%
$82.68K
+5,701%
Hykes Kevin
PRES & CEO
$274.97K (2)
$61.35K (1) scheduled
+$213.62K
284,237
1.07%
$828.47K
VERRASTRO PAUL
CHIEF MKTG & STRAT OFFICER
$171.52K (7) scheduled
−$171.52K
60,551
0.2273%
$176.49K
Binkowski Brent
CHIEF OPERATING OFFICER
$76.43K (1)
$3.34K (1) scheduled
+$73.09K
56,514
0.2121%
$164.72K
SLATTERY JOSEPH P
Director
$71.74K (3)
+$71.74K
39,365
0.1478%
$114.74K
John Robert Allen
Chief Revenue Officer
$31.33K (1) scheduled
−$31.33K
86,036
0.3229%
$250.77K
OASHEIM JARED
CHIEF FINANCIAL OFFICER
$13.78K (1) scheduled
−$13.78K
96,703
0.3630%
$281.86K
Adamson Philip B.
Chief Medical Officer
$9.97K (1) scheduled
−$9.97K
61,578
0.2311%
$179.48K
+3,247%
BRUHN-DING DEAN
VP OF REG. AFFAIRS AND QA
54,648
0.2051%
$159.28K
+867.6%
Morrison Gregory
CHIEF HUMAN RESOURCES OFFICER
34,000
0.1276%
$99.10K
BRINTNALL JOHN
CHIEF STRATEGY OFFICER AND SEC
31,527
0.1183%
$91.89K
+227.5%
DALE MICHAEL D
Director
29,005
0.1089%
$84.54K
Yared Nadim
CHIEF EXECUTIVE OFFICER
26,255
0.0985%
$76.53K
SHADAN MARTHA
Director
8,720
0.0327%
$25.42K
Hill, Mitch C.
Director
8,720
0.0327%
$25.42K
Ballinger Kevin J.
Director
8,720
0.0327%
$25.42K
Palmer Craig E.
SVP, U.S. SALES
1,229
0.0046%
$3.58K
Galle Liz
VP OF GLOBAL CLINICAL RESEARCH
778
0.0029%
$2.27K
Behbahani Ali
Director
316
0.0012%
$921.05
Johnson & Johnson Innovation - JJDC, Inc. entity
10% owner
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
Binkowski Brent
13 Aug 2026
CHIEF OPERATING OFFICER
Buy
26,223
$2.91
$76.43K
Binkowski Brent
12 Aug 2026
CHIEF OPERATING OFFICER
Sold on a plan
1,309
$2.55
$3.34K
John Robert Allen
2 Mar 2026
Chief Revenue Officer
Sold on a plan
3,964
$7.90
$31.33K
OASHEIM JARED
2 Mar 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
1,744
$7.90
$13.78K
VERRASTRO PAUL
2 Mar 2026
CHIEF MKTG & STRAT OFFICER
Sold on a plan
1,284
$7.90
$10.15K
Hykes Kevin
2 Mar 2026
PRES & CEO
Sold on a plan
7,763
$7.90
$61.35K
Adamson Philip B.
2 Mar 2026
Chief Medical Officer
Sold on a plan
1,262
$7.90
$9.97K
Jain Mudit K.
20 Feb 2026
Director
Buy indirect
46,800
$6.36
$297.59K
Jain Mudit K.
18 Feb 2026
Director
Buy
600
$4.64
$2.79K
JOHNSON & JOHNSON
26 Nov 2025
10% owner
Sell indirect
6,337
$10.03
$63.56K
JOHNSON & JOHNSON
24 Nov 2025
10% owner
Sell indirect
2,200
$10.06
$22.13K
JOHNSON & JOHNSON
21 Nov 2025
10% owner
Sell indirect
500
$10.00
$5.00K
JOHNSON & JOHNSON
12 Nov 2025
10% owner
Sell indirect
1,000
$10.00
$10.00K
JOHNSON & JOHNSON
7 Nov 2025
10% owner
Sell indirect
200
$10.00
$2.00K
JOHNSON & JOHNSON
6 Nov 2025
10% owner
Sell indirect
52,332
$10.21
$534.31K
Nielsen Kirk G.
15 May 2025
Director
Buy indirect
10,966
$5.45
$59.80K
Nielsen Kirk G.
14 May 2025
Director
Buy indirect
61,200
$5.23
$320.36K
Jain Mudit K.
13 May 2025
Director
Buy
150
$5.26
$789.00
Nielsen Kirk G.
13 May 2025
Director
Buy indirect
101,413
$5.29
$536.31K
Hykes Kevin
12 May 2025
PRES & CEO
Buy
5,000
$4.84
$24.20K
Jain Mudit K.
12 May 2025
Director
Buy
1,500
$4.66
$6.99K
Nielsen Kirk G.
12 May 2025
Director
Buy indirect
25,200
$4.79
$120.67K
VERRASTRO PAUL
19 Nov 2024
CHIEF MKTG & STRAT OFFICER
Sold after exercise
1,430
$13.58
$19.42K
SLATTERY JOSEPH P
15 Aug 2024
Director
Buy
3,000
$8.10
$24.30K
SLATTERY JOSEPH P
8 Aug 2024
Director
Buy
3,000
$8.24
$24.72K
SLATTERY JOSEPH P
6 Aug 2024
Director
Buy
2,500
$9.09
$22.73K
Hykes Kevin
5 Aug 2024
PRES & CEO
Buy
30,000
$8.36
$250.77K
Palmer Craig E.
25 Mar 2024
SVP, U.S. SALES
Exercised, kept
151
$0.24
$35.79
Palmer Craig E.
25 Mar 2024
SVP, U.S. SALES
Exercised, kept
404
$0.24
$95.75
Palmer Craig E.
25 Mar 2024
SVP, U.S. SALES
Exercised, kept
379
$0.24
$89.82
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
79
$5.14
$406.14
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
252
$3.96
$996.66
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
142
$1.19
$168.41
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
442
$1.19
$524.21
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
300
$0.24
$71.10
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
584
$0.24
$138.41
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
489
$0.24
$115.89
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
758
$0.24
$179.65
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
85
$0.24
$20.15
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
23
$0.24
$5.45
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
71
$0.24
$16.83
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
118
$0.24
$27.97
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
165
$0.24
$39.11
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
189
$0.24
$44.79
JOHNSON & JOHNSON
29 Feb 2024
10% owner
Exercised, kept indirect
158
$0.24
$37.45
VERRASTRO PAUL
20 Feb 2024
CHIEF MKTG & STRAT OFFICER
Sold after exercise
2,545
$21.91
$55.75K
JOHNSON & JOHNSON
16 Feb 2024
10% owner
Sold after exercise indirect
3,725
$25.81
$96.14K
Yared Nadim
29 Jan 2024
CHIEF EXECUTIVE OFFICER
Exercised, kept
1,945
$0.24
$460.97
Yared Nadim
29 Jan 2024
CHIEF EXECUTIVE OFFICER
Exercised, kept
4,055
$0.24
$961.04
SLATTERY JOSEPH P
28 Dec 2023
Director
Exercised, kept
96
$3.96
$379.68
SLATTERY JOSEPH P
28 Dec 2023
Director
Exercised, kept
174
$1.19
$206.36
SLATTERY JOSEPH P
28 Dec 2023
Director
Exercised, kept
1,456
$0.24
$345.07
SLATTERY JOSEPH P
28 Dec 2023
Director
Exercised, kept
224
$0.24
$53.09
Behbahani Ali
14 Dec 2023
Director
Exercised, kept
316
$0.24
$74.89
Galle Liz
16 Oct 2023
VP OF GLOBAL CLINICAL RESEARCH
Exercised, kept
778
$0.24
$184.39
OASHEIM JARED
18 Sep 2023
CHIEF FINANCIAL OFFICER
Exercised, kept
5,335
$3.96
$21.10K
OASHEIM JARED
18 Sep 2023
CHIEF FINANCIAL OFFICER
Exercised, kept
527
$0.24
$124.90
VERRASTRO PAUL
3 Aug 2023
CHIEF MKTG & STRAT OFFICER
Sell
628
$18.55
$11.65K
VERRASTRO PAUL
31 Jul 2023
CHIEF MKTG & STRAT OFFICER
Sold after exercise
1,122
$17.49
$19.63K
Palmer Craig E.
16 May 2023
SVP, U.S. SALES
Exercised, kept
295
$0.24
$69.92
VERRASTRO PAUL
28 Nov 2022
CHIEF MKTG & STRAT OFFICER
Sold after exercise
600
$12.52
$7.51K
VERRASTRO PAUL
28 Nov 2022
CHIEF MKTG & STRAT OFFICER
Sold after exercise
4,000
$11.85
$47.42K
OASHEIM JARED
2 Jun 2022
CHIEF FINANCIAL OFFICER
Exercised, kept
2,633
$0.24
$624.02
OASHEIM JARED
2 Jun 2022
CHIEF FINANCIAL OFFICER
Exercised, kept
3,160
$0.24
$748.92
OASHEIM JARED
2 Jun 2022
CHIEF FINANCIAL OFFICER
Exercised, kept
2,528
$0.24
$599.14
OASHEIM JARED
2 Jun 2022
CHIEF FINANCIAL OFFICER
Exercised, kept
1,264
$0.24
$299.57
Nielsen Kirk G.
24 May 2022
Director
Buy indirect
8,070
$5.05
$40.75K
Nielsen Kirk G.
23 May 2022
Director
Buy indirect
4,432
$5.04
$22.34K
Nielsen Kirk G.
20 May 2022
Director
Buy indirect
13,387
$5.04
$67.41K
Nielsen Kirk G.
19 May 2022
Director
Buy indirect
10,976
$5.04
$55.30K
Nielsen Kirk G.
5 May 2022
Director
Buy indirect
3,992
$6.00
$23.94K
Nielsen Kirk G.
4 May 2022
Director
Buy indirect
25,503
$5.99
$152.76K
Nielsen Kirk G.
3 May 2022
Director
Buy indirect
32,809
$6.00
$196.76K
Nielsen Kirk G.
2 May 2022
Director
Buy indirect
41,988
$5.97
$250.67K
Nielsen Kirk G.
28 Apr 2022
Director
Buy indirect
100
$5.97
$597.00
Yared Nadim
25 Apr 2022
CHIEF EXECUTIVE OFFICER
Exercised, kept
6,059
$0.24
$1.44K
BRINTNALL JOHN
22 Apr 2022
CHIEF STRATEGY OFFICER AND SEC
Exercised, kept
1,264
$0.24
$299.57
BRINTNALL JOHN
22 Apr 2022
CHIEF STRATEGY OFFICER AND SEC
Exercised, kept
3,792
$0.24
$898.70
BRINTNALL JOHN
22 Apr 2022
CHIEF STRATEGY OFFICER AND SEC
Exercised, kept
2,221
$0.24
$526.38
BRINTNALL JOHN
22 Apr 2022
CHIEF STRATEGY OFFICER AND SEC
Exercised, kept
2,584
$0.24
$612.41
BRINTNALL JOHN
22 Apr 2022
CHIEF STRATEGY OFFICER AND SEC
Exercised, kept
1,590
$0.24
$376.83
Jain Mudit K.
28 Feb 2022
Director
Buy
600
$9.03
$5.42K
Nielsen Kirk G.
24 Feb 2022
Director
Buy indirect
3,400
$8.24
$28.01K
Nielsen Kirk G.
23 Feb 2022
Director
Buy indirect
38,200
$8.04
$307.14K
Nielsen Kirk G.
22 Feb 2022
Director
Buy indirect
40,008
$7.94
$317.66K
Nielsen Kirk G.
18 Feb 2022
Director
Buy indirect
26,659
$7.92
$211.23K
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
5,158
$0.24
$1.22K
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
2,275
$0.24
$539.18
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
2,528
$0.24
$599.14
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
1,590
$0.24
$376.83
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
378
$0.24
$89.59
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
821
$0.24
$194.58
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
1,169
$0.24
$277.05
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
2,528
$0.24
$599.14
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
1,264
$0.24
$299.57
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
1,264
$0.24
$299.57
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
2,862
$0.24
$678.29
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
12,383
$0.24
$2.93K
BRUHN-DING DEAN
8 Feb 2022
VP of Reg. Affairs and QA
Exercised, kept
780
$0.24
$184.86
Yared Nadim
3 Feb 2022
Chief Executive Officer
Exercised, kept
1,266
$0.24
$300.04
Yared Nadim
3 Feb 2022
Chief Executive Officer
Exercised, kept
5,916
$0.24
$1.40K
Yared Nadim
3 Feb 2022
Chief Executive Officer
Exercised, kept
3,792
$0.24
$898.70
Yared Nadim
3 Feb 2022
Chief Executive Officer
Exercised, kept
5,057
$0.24
$1.20K
Yared Nadim
3 Feb 2022
Chief Executive Officer
Exercised, kept
2,659
$0.24
$630.18
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
584
$1.19
$692.62
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
758
$0.24
$179.65
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
316
$0.24
$74.89
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
189
$0.24
$44.79
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
189
$0.24
$44.79
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
189
$0.24
$44.79
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
189
$0.24
$44.79
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
2,528
$0.24
$599.14
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
316
$0.24
$74.89
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
316
$0.24
$74.89
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
3,917
$0.24
$928.33
SLATTERY JOSEPH P
13 Jan 2022
Director
Exercised, kept
2,149
$0.24
$509.31
BRINTNALL JOHN
30 Dec 2021
Chief Strategy Officer and Sec
Exercised, kept
2,550
$0.24
$604.35
Yared Nadim
28 Dec 2021
Chief Executive Officer
Exercised, kept
2,080
$0.24
$492.96
SLATTERY JOSEPH P
30 Nov 2021
Director
Exercised, kept
3,000
$0.24
$720.00
BRUHN-DING DEAN
24 Nov 2021
VP of Reg. Affairs and QA
Exercised, kept
14,000
$0.24
$3.36K
Yared Nadim
22 Nov 2021
Chief Executive Officer
Exercised, kept
11,006
$0.24
$2.64K
Jain Mudit K.
19 Nov 2021
Director
Buy
300
$13.69
$4.11K
Jain Mudit K.
18 Nov 2021
Director
Buy
875
$14.63
$12.80K
Jain Mudit K.
12 Aug 2021
Director
Buy
625
$19.72
$12.33K
Pardo Geoffrey B
2 Jul 2021
Director
Buy indirect
275,000
$18.00
$4.95M
Jain Mudit K.
2 Jul 2021
Director
Buy indirect
222,222
$18.00
$4.00M
NEHRA JOHN M
2 Jul 2021
Director
Buy
27,777
$18.00
$499.99K
GSK plc
2 Jul 2021
10% owner
Buy indirect
275,000
$18.00
$4.95M
NEW ENTERPRISE ASSOCIATES 10 L P
2 Jul 2021
10% owner
Buy
225,500
$18.00
$4.06M
NEA PARTNERS 10 L P
2 Jul 2021
10% owner
Buy indirect
24,750
$18.00
$445.50K
NEA PARTNERS 10 L P
2 Jul 2021
10% owner
Buy indirect
225,500
$18.00
$4.06M
Jain Mudit K.
1 Jul 2021
Director
Buy
1,000
$25.10
$25.10K
NEHRA JOHN M
1 Jul 2021
Director
Buy indirect
50
$25.80
$1.29K
NEHRA JOHN M
30 Jun 2021
Director
Buy indirect
50
$27.43
$1.37K

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 6
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 16,679,432
History held since 1 Jul 2021